
Mirion Technologies (MIR) Stock
Publicly traded company. Here's the price, business snapshot, and what's worth knowing about Mirion Technologies in July 2026.
Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets. The Company's segments include Medical, and Nuclear & Safety. The Medical segment includes products and services for radiation therapy, nuclear medicine and personal dosimetry. This segment’s principal product offering is in Radiation Therapy Quality Assurance, which includes solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy. The Nuclear & Safety segment includes products and services focused on addressing critical radiation safety, measurement and analysis applications across nuclear energy, laboratories and research and other industrial markets such as defense. For nuclear power plants (NPPs), it sells products and services for use at any stage of their life (construction, operation, decommissioning and dismantling).
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Mirion Technologies' stock, expecting significant growth potential moving forward.
Financial Health
Mirion Technologies is performing well with solid revenue and cash flow, indicating strong operational efficiency.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Discover More Opportunities
AMETEK INC
Ametek is a leading global manufacturer of electronic instruments and electromechanical devices with operations in the United States and across the world.
APPLIED INDUSTRIAL TECHNOLOGIES INC
Distributes industrial and mechanical products to industrial customers in North America.
ADVANCED ENERGY INDUSTRIES
Advanced Energy Industries Inc manufactures and supplies power conversion technology solutions.
Baskets Featuring MIR
Missile Production Scale-Up: Could It Boost Suppliers?
Lockheed Martin has broken ground on a massive expansion of its Alabama missile production plant to meet surging U.S. defense demands. This infrastructure scale-up creates a strong investment opportunity in the specialized suppliers and component manufacturers that feed into the nation's rapidly growing aerospace supply chain.
Published: 24 May 2026
Explore BasketRadiopharma Revolution: Promise Meets Market Risk
Aktis Oncology's highly successful and upsized IPO, strongly backed by pharma giant Eli Lilly, signals a surge of investor confidence in radiopharmaceutical cancer therapies. This theme focuses on the companies poised to ride this wave of investment and innovation in one of biotech's most promising frontiers.
Published: 9 January 2026
Explore BasketWhy invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.